SRA Wins $100 Million Medical Research Deal from DoD

SRA International, Inc. (NYSE: SRX) won a deal from the Department of Defense (DoD) on a re-compete “to support the receipt and scientific review of research grant applications for DoD’s Congressionally Directed Medical Research Programs (CDMRP).”

The contract would worth as much as $100 million over five years, if all options are exercised.

“CDMRP plays an important role in supporting disease-specific research, and in addressing the issues faced by our military members and their families, ” said SRA Health Programs Vice President Paul Nedzbala. “SRA fully shares this mission and we are proud that CDMRP will allow us to continue this partnership. By leveraging our scientific expertise, information technology and administrative support, SRA has been able to provide an unsurpassed level of service to CDMRP. Our team is focused on CDMRP’s mission as we make meaningful contributions to advances in important areas of biomedical research.”

Check Also


SAIC Awarded TSA Test & Evaluation Support BPA

Science Applications International Corp. (NYSE: SAIC) has been awarded a potential $40M blanket purchase agreement for operational test and evaluation services to the Transportation Security Administration, according to an award notice posted Thursday.

US Air Force

Air Force Selects Boeing, Lockheed, Raytheon Technologies for Hypersonic Cruise Missile Tech Design Program

The U.S. Air Force has indicated its intent to solicit design proposals from Boeing (NYSE: BA), Lockheed Martin (NYSE: LMT) and Raytheon Technologies (NYSE: RTX) for a hypersonic cruise missile technology that can be launched from a fighter or a bomber aircraft.